Mayport LLC’s AbbVie ABBV Stock Holding History

Mayport LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82M	Sell	7,247 -22	-0.3%	-$4.73K	0.28%	40
2026 Q1	$1.58M	Buy	7,269 +111	+2%	+$24.6K	0.29%	39
2025 Q4	$1.64M	Sell	7,158 -92	-1%	-$21K	0.33%	34
2025 Q3	$1.68M	Buy	7,250 +129	+2%	+$26.3K	0.36%	30
2025 Q2	$1.32M	Sell	7,121 -13	-0.2%	-$2.42K	0.32%	34
2025 Q1	$1.49M	Buy	7,134 +581	+9%	+$113K	0.41%	28
2024 Q4	$1.16M	Sell	6,553 -120	-2%	-$22.1K	0.34%	35
2024 Q3	$1.32M	Buy	6,673 +376	+6%	+$70.2K	0.42%	31
2024 Q2	$1.08M	Buy	6,297 +1	+0%	+$166	0.38%	35
2024 Q1	$1.15M	Sell	6,296 -2,568	-29%	-$443K	0.44%	34
2023 Q4	$1.37M	Buy	8,864 +27	+0.3%	+$3.94K	0.62%	27
2023 Q3	$1.32M	Buy	8,837 +3,575	+68%	+$525K	0.72%	24
2023 Q2	$709K	Hold	5,262	–	–	0.4%	31
2023 Q1	$839K	Hold	5,262	–	–	0.52%	29
2022 Q4	$850K	Sell	5,262 -93	-2%	-$14.3K	0.64%	28
2022 Q3	$719K	Sell	5,355 -65	-1%	-$9.33K	0.59%	28
2022 Q2	$830K	Buy	5,420 +404	+8%	+$61.7K	0.68%	25
2022 Q1	$813K	Sell	5,016 -2,595	-34%	-$377K	0.56%	26
2021 Q4	$1.03M	Buy	+7,611	New	+$899K	0.77%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mayport LLC's ABBV Position: Q2 2026 in Review

Mayport LLC reduced its AbbVie (ABBV) stake by 0.3% in Q2 2026, selling an estimated $4.73K and leaving 7,247 shares worth $1.82M. The position accounts for 0.28% of the portfolio, ranked #40.

Mayport LLC first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mayport LLC held 7,247 shares of AbbVie worth $1.82M as of Q2 2026.
Mayport LLC sold 22 AbbVie shares in Q2 2026, an estimated $4.73K.
AbbVie made up 0.28% of Mayport LLC's portfolio in Q2 2026, its #40 holding.
Mayport LLC first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mayport LLC's 13F filing for Q2 2026, filed 7 Aug 2026.